A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

The purpose of this study is to understand the trade-offs that participants with surgically treated melanoma would be willing to make among key features and outcomes of adjuvant anti-cancer treatments or no adjuvant treatment / observation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Melanoma Behavior Health Behavior Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Nevi and Melanomas Patient Preference Patient Satisfaction Skin Diseases Skin Neoplasms Skin and Connective Tissue Diseases Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Local Institution

Melbourne, Victoria, 3084, Australia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Self-reported medical diagnosis of stage II or stage III melanoma
Have been resected (had surgery) for their melanoma within 12 months prior to study participation

Exclusion criteria

Self-reported stage IIa
Self-reported recurrence of melanoma after surgery

Other protocol-defined inclusion/exclusion criteria apply

Treatment and study plan

Primary outcomes

Preference weights or utilities (a measure of relative preference; on a continuous variable scale) for each treatment attribute level based on responses to the Discrete Choice Experiment (DCE) choice tasks

Time frame: At Baseline

Sponsors and collaborators

Lead sponsor

Bristol-Myers Squibb

Industry

Registry information

Official study title

Adjuvant Melanoma Stakeholder Treatment Preference Study

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Nov 10, 2021
Registry last updated: Jun 30, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting